RESUMO

Parasitic diseases have a significant impact on human and animal health, representing a major hazard to the public and causing economic and health damage worldwide. Extracellular vesicles (EVs) have long been recognized as diagnostic and therapeutic tools but are now also known to be implicated in the natural history of parasitic diseases and host immune response modulation. Studies have shown that EVs play a role in parasitic disease development by interacting with parasites and communicating with other types of cells. This review highlights the most recent research on EVs and their role in several aspects of parasite-host interactions in five key parasitic diseases: Chagas disease, malaria, toxoplasmosis, leishmaniasis and helminthiases. We also discuss the potential use of EVs as diagnostic tools or treatment options for these infectious diseases.

Assuntos

RESUMO

Aptamers are single-stranded DNA or RNA sequences that adopt unique three-dimensional structures that allow them to recognize a specific target with high affinity. They can potentially be used for the diagnosis of diseases, as new therapeutic agents, for the detection of food risks, as biosensors, for the detection of toxins, and as drug carriers and nanoparticle markers, among other applications. To date, an aptamer called pegaptanib is the only aptamer approved by the Food and Drug Administration (FDA) for commercial use. Other aptamers are in different clinical stages of development for the treatment of different diseases. In parasitology, investigations carried out with parasites such as Leishmania spp. allowed the acquisition of aptamers that recognize the polyA-binding protein LiPABP and may have potential applications in research and diagnosis and even as therapeutic agents. Regarding malaria, aptamers have been obtained that allow the identification of infected erythrocytes or inhibit the formation of rosettes, along with those that provide promising alternatives for diagnosis by specifically detecting the protein lactate dehydrogenase (PfLDH). In Cryptosporidium parvum allow the detection of oocysts in contaminated food or water. In Entamoeba histolytica, two aptamers called C4 and C5, which inhibit the proliferation of trophozoites in vitro and have potential use as therapeutic agents, have been isolated. Aptamers obtained against Trypanosoma cruzi inhibit the invasion of LLC-MK2 (from monkey kidney) cells by 50-70%, and in T. brucei, aptamers with the potential to transport toxic molecules to the parasitic lysosome were identified as a novel therapeutic strategy.

Los aptámeros son secuencias de ADN o ARN de cadena sencilla que adoptan la forma de estructuras tridimensionales únicas, lo cual les permite reconocer un blanco específico con gran afinidad. Sus usos potenciales abarcan, entre otros, el diagnóstico de enfermedades, el desarrollo de nuevos agentes terapéuticos, la detección de riesgos alimentarios, la producción de biosensores, la detección de toxinas, el transporte de fármacos en el organismo y la señalización de nanopartículas. El pegaptanib es el único aptámero aprobado para uso comercial por la Food and Drug Administration (FDA).  En parasitología, se destacan los estudios que se vienen realizando en Leishmania spp., con la obtención de aptámeros que reconocen la proteína de unión a poliA (LiPABP) y que pueden tener potencial utilidad en la investigación, el diagnóstico y el tratamiento de la leishmaniasis. En cuanto a la malaria, se han obtenido aptámeros que permiten identificar eritrocitos infectados e inhiben la formación de rosetas, y otros que prometen ser alternativas para el diagnóstico al detectar de forma específica la proteína lactato deshidrogenasa (PfLDH). Para Cryptosporidium parvuum se han seleccionado aptámeros que detectan ooquistes a partir de alimentos o aguas contaminadas. Para Entamoeba histolytica se han aislado dos aptámeros llamados C4 y C5, que inhiben la proliferación in vitro de los trofozoítos y tienen potencial terapéutico. Los aptámeros contra Trypanosoma cruzi inhiben la invasión de células LLC-MK2 (de riñón de mono) en un 50 a 70 % y aquellos contra T. brucei transportan moléculas tóxicas al lisosoma parasitario como una novedosa estrategia terapéutica.

Assuntos

RESUMO

The CCR5 molecule was reported in 1996 as the main HIV-1 co-receptor. In that same year, the CCR5Δ32 genetic variant was described as a strong protective factor against HIV-1 infection. These findings led to extensive research regarding the CCR5, culminating in critical scientific advances, such as the development of CCR5 inhibitors for the treatment of HIV infection. Recently, the research landscape surrounding CCR5 has begun to change. Different research groups have realized that, since CCR5 has such important effects in the chemokine system, it could also affect other different physiological systems. Therefore, the effect of reduced CCR5 expression due to the presence of the CCR5Δ32 variant began to be further studied. Several studies have investigated the role of CCR5 and the impacts of CCR5Δ32 on autoimmune and inflammatory diseases, various types of cancer, and viral diseases. However, the role of CCR5 in diseases caused by bacteria and parasites is still poorly understood. Therefore, the aim of this article is to review the role of CCR5 and the effects of CCR5Δ32 on bacterial (brucellosis, osteomyelitis, pneumonia, tuberculosis and infection by Chlamydia trachomatis) and parasitic infections (toxoplasmosis, leishmaniasis, Chagas disease and schistosomiasis). Basic information about each of these infections was also addressed. The neglected role of CCR5 in fungal disease and emerging studies regarding the action of CCR5 on regulatory T cells are briefly covered in this review. Considering the "renaissance of CCR5 research," this article is useful for updating researchers who develop studies involving CCR5 and CCR5Δ32 in different infectious diseases.

Assuntos

RESUMO

Neurocysticercosis is the most common parasitic neurological disease worldwide, yet in Europe, it remains relatively uncommon, with many practitioners rarely seeing a case. However, immigration and international travel mean that it is becoming increasingly recognised and diagnosed in developed countries. Being a treatable condition, it is essential to be familiar with the diagnosis and to appreciate its mimics and breadth of its possible clinical presentations.

Assuntos

RESUMO

Objective: to describe the causes of hospitalization of Brazilian children under five years old. Methods: this is a systematic review of articles published from 2008 to 2015, searched in the databases Medline and LILACS; selected studies were critically analyzed through a validated instrument. Results: eleven articles were included, four of them are ecological and seven are cross-sectional studies; respiratory diseases (n=5), parasitic infections (n=4) and perinatal diseases (n=2) were the main causes for hospitalizations in the reviwed articles; in the studies that analyzed the sensitive conditions, pneumonia (n=6), gastroenteritis (n=5), and asthma (n=5) were the mais causes pointed out. Conclusion: respiratory, parasitic and perinatal diseases revealed to be the main causes for hospitalizations in Brazilian children; pneumonia, gastroenteritis, and asthma constitute the most important of hospitalizations, treatable in the ambulatory health care.

Assuntos

RESUMO

ABSTRACT Aptamers are short single-stranded RNA or DNA oligonucleotides that are capable of binding various biological targets with high affinity and specificity. Their identification initially relies on a molecular process named SELEX (Systematic Evolution of Ligands by EXponential enrichment) that has been later modified in order to improve aptamer sensitivity, minimize duration and cost of the assay, as well as increase target types. Several biochemical modifications can help to enhance aptamer stability without affecting significantly target interaction. As a result, aptamers have generated a large interest as promising tools to compete with monoclonal antibodies for detection and inhibition of specific markers of human diseases. One aptamer-based drug is currently authorized and several others are being clinically evaluated. Despite advances in the knowledge of parasite biology and host-parasite interactions from "omics" data, protozoan parasites still affect millions of people around the world and there is an urgent need for drug target discovery and novel therapeutic concepts. In this context, aptamers represent promising tools for pathogen identification and control. Recent studies have reported the identification of "aptasensors" for parasite diagnosis, and "intramers" targeting intracellular proteins. Here we discuss various strategies that have been employed for intracellular expression of aptamers and expansion of their possible application, and propose that they may be suitable for the clinical use of aptamers in parasitic infections.

Assuntos

RESUMO

Aptamers are short single-stranded RNA or DNA oligonucleotides that are capable of binding various biological targets with high affinity and specificity. Their identification initially relies on a molecular process named SELEX (Systematic Evolution of Ligands by EXponential enrichment) that has been later modified in order to improve aptamer sensitivity, minimize duration and cost of the assay, as well as increase target types. Several biochemical modifications can help to enhance aptamer stability without affecting significantly target interaction. As a result, aptamers have generated a large interest as promising tools to compete with monoclonal antibodies for detection and inhibition of specific markers of human diseases. One aptamer-based drug is currently authorized and several others are being clinically evaluated. Despite advances in the knowledge of parasite biology and host-parasite interactions from "omics" data, protozoan parasites still affect millions of people around the world and there is an urgent need for drug target discovery and novel therapeutic concepts. In this context, aptamers represent promising tools for pathogen identification and control. Recent studies have reported the identification of "aptasensors" for parasite diagnosis, and "intramers" targeting intracellular proteins. Here we discuss various strategies that have been employed for intracellular expression of aptamers and expansion of their possible application, and propose that they may be suitable for the clinical use of aptamers in parasitic infections.

Assuntos

RESUMO

Background: Feline demodicosis is considered an uncommon dermatopathy in cats that is mainly caused by the mite Demodex cati, but in few cases D. gatoi may be involved. Although the clinical aspects and pathogeny of feline demodicosis are not completely understood, its clinical expression is believed to be associated with the presence of primary immunosuppressive agents. Thus, the aim of this study is to report the diagnosis and treatment of an infested cat by D. cati, associated with mixed intestinal parasitic infection.Case: An approximately 1-year-old male short hair cat which was grown in a rural area was presented at the Veterinary Hospital of the Federal University of Pampa (Unipampa) in Uruguaiana, Rio Grande do Sul. The cat had alopecia, itching, excoriations on neck and head, and softened feces as clinical signs. Performed skin scrapings revealed eggs, larvae and adult forms of D. cati. In order to find possible immunosuppressive agents, exams for detection of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) were also performed. They revealed, however, negative results for FIV and FeLV infections. Moreover, coproparasitologic analysis revealed the presence of the intestinal parasites Trichuris sp., Ancylostoma sp., and Spirometra mansonoides. Thus, it was decided to proceed the treatment utilizing 0.2 mg/kg of moxidectin subcutaneously every four [...](AU)

Assuntos

RESUMO

Background: Feline demodicosis is considered an uncommon dermatopathy in cats that is mainly caused by the mite Demodex cati, but in few cases D. gatoi may be involved. Although the clinical aspects and pathogeny of feline demodicosis are not completely understood, its clinical expression is believed to be associated with the presence of primary immunosuppressive agents. Thus, the aim of this study is to report the diagnosis and treatment of an infested cat by D. cati, associated with mixed intestinal parasitic infection.Case: An approximately 1-year-old male short hair cat which was grown in a rural area was presented at the Veterinary Hospital of the Federal University of Pampa (Unipampa) in Uruguaiana, Rio Grande do Sul. The cat had alopecia, itching, excoriations on neck and head, and softened feces as clinical signs. Performed skin scrapings revealed eggs, larvae and adult forms of D. cati. In order to find possible immunosuppressive agents, exams for detection of feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV) were also performed. They revealed, however, negative results for FIV and FeLV infections. Moreover, coproparasitologic analysis revealed the presence of the intestinal parasites Trichuris sp., Ancylostoma sp., and Spirometra mansonoides. Thus, it was decided to proceed the treatment utilizing 0.2 mg/kg of moxidectin subcutaneously every four [...]

Assuntos

RESUMO

A esquistossomose é uma das parasitoses mais prevalentes no mundo e é um grande problema de saúde pública, principalmente nos países em desenvolvimento. Atualmente a medida mais utilizada para o controle da doença é a quimioterapia. Entretanto, sabe-se que mesmo após o tratamento os indivíduos se reinfectam. Sabe-se também que há uma estreita relação entre os fatores demográficos, socioeconômicos e comportamentais na dinâmica da transmissão da esquistossomose. Diante disso, a realização deste estudo teve como objetivo analisar a reinfecção pelo Schistosoma mansoni entre escolares com idade de 5 a 15 anos. Os participantes foram 407 crianças e adolescentes infectados pelo S. mansoni e residentes no município de Ponto dos Volantes, nas comunidades de Palha, Astraluta, Caju (Jequitinhonha) e Córrego São João (Itaobim), sendo todas essas áreas consideradas endêmicas para a esquistossomose. No início do estudo, todos os voluntários foram tratados com Praziquantel e responderam aos questionários socioeconômico e de contato com a água. Foram coletadas, também, as coordenadas geográficas das suas residências. Um ano após o tratamento foram realizados exames parasitológicos de fezes de todos os escolares para avaliar a reinfecção tendo sido encontrada uma taxa de 21,6 %. O modelo multivariado mostrou que a carga parasitária pré-tratamento (p < 0,001) e a falta de fornecimento de água tratada (p = 0,010) mantiveram-se associadas à reinfecção. Aqueles que reinfectaram tiveram um maior contato com água potencialmente contaminada apesar da diferença não ter sido significativa. A análise espacial apontou que, em todas as áreas estudadas, a reinfecção ocorreu de forma heterogênea. Concluiu-se que a taxa de reinfecção pelo S. mansoni é preocupante e que possuir uma alta carga parasitária antes do tratamento e residir em local onde não há água tratada foram os principais fatores de risco para a reinfecção pelo S. mansoni.

Schistosomiasis is one of the most prevalent parasitic diseases in the world and is a major public health problem, particularly in developing countries. Currently the most commonly used measure for controlling the condition is chemotherapy. However, after the treatment, the individuals become infected again. It is well known that there is a close relationship between demographic, socioeconomic and behavioral factors in the dynamics of schistosomias is transmission. Therefore, this study aimed to analyze reinfection by Schistosoma mansoni in school children aged 5-15 years. Participants were 407 children and adolescents infected with S. mansoni and residents in the municipality of Ponto dos Volantes, and the communities of Palha, Astraluta, Caju and Córrego São João, all of which are endemic areas for schistosomiasis. At baseline, all subjects were treated with Praziquantel, responded to socioeconomic and water contact questionnaires. The geographical coordinates of all houses were collected. One year after the treatment another faecal exam was performed to evaluate reinfection rates. The results showed a reinfection rate of 21.6%. The multivariate model showed that parasite load before treatment (p < 0.001) and lack of treated water supply (p = 0.010) remained associated to reinfection. Spatial analys is showed that in all areas studied reinfection occurred heterogeneously. It is concluded that the reinfection rate is worrisome and having high intensity of infection before treatment and leaving in areas with no treated water were considered the main risk factors to re-infection with S. mansoni.

Assuntos